UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W
Number of items: 139.

A

Ah-See, MLW; Makris, A; Burcombe, RJ; Davies, C; Cladd, HJ; Padhani, AR; Harris, AL; (2003) Evaluation of plasma & serum vascular endothelial growth factor (VEGF) during neoadjuvant chemotherapy for primary breast cancer. British Journal of Cancer , 88 S44 - S44.

Ah-See, MLW; Taylor, NJ; Makris, A; Burcombe, RJ; Stirling, JJ; Cladd, HJ; ... Padhani, AR; + view all (2003) Valuation of multi-functional dynamic contrast-enhanced MRI to predict response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 88 S41 - S41.

Ahmedzai, S; Hoskin, PJ; (2003) Assessment and management of malignant disease. In: Muers, MF, (ed.) Oxford Textbook: Supportive Care in Respiratory Disease. Oxford University Press: Oxford.

Ann, F; (2003) Thalidomide: horror and redemption. Cancer Nursing Practice , 2 (25) 10 - 12.

Ardeshna, KM; Smith, P; Norton, A; Hancock, BW; Hoskin, PJ; MacLennan, KA; ... Brit Natl Lymphoma Invest,; + view all (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. LANCET , 362 (9383) 516 - 522.

Arkenau, H-T; Kruse, F; Porschen, R; Jend, HH; (2003) Zur differenzialdiagnose des Morbus Crohn: Invagination des kolons. Zeitschrift fur Gastroenterologie , 41 (7) 663 - 666. 10.1055/s-2003-40549.

Arkenau, HT; Bermann, A; Rettig, K; Strohmeyer, G; Porschen, R; Arbeitsgemeinschaft Gastrointestinale Onkologie,; (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol , 14 (3) 395 - 399.

Arkenau, HT; Kruse, F; Jend, HH; Porschen, R; (2003) [Differential diagnosis of morbus Crohn disease: intussusception of the colon]. Z Gastroenterol , 41 (7) 663 - 666. 10.1055/s-2003-40549.

Assersohn, L; Salter, J; Powles, TJ; A'Hern, R; Makris, A; Gregory, RK; ... Dowsett, M; + view all (2003) Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer. Breast Cancer Research and Treatment , 82 (2) 113 - 123.

Atalay, G; Biganzoli, L; Renard, F; Paridaens, R; Cufer, T; Coleman, R; ... EORTC Breast Canc Early Clin,; + view all (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. EUR J CANCER , 39 (17) 2439 - 2449. 10.1016/S0959-8049(03)00601-4.

B

Balk, J; Chew, SK; Leaver, CJ; McCabe, PF; (2003) The intermembrane space of plant mitochondria contains a DNase activity that may be involved in programmed cell death. Plant J , 34 (5) 573 - 583.

BBC, NO; (2003) Blood test spots 'asbestos cancer'. UNSPECIFIED

BBC, NO; (2003) Scans help spot lung cancer early. UNSPECIFIED

BBC, NO; (2003) Thalidomide trials to fight cancer. UNSPECIFIED

BBC, NO; (2003) Warning to heed lung cancer signs. UNSPECIFIED

BBC, R4; (2003) Thalidomide Trial. UNSPECIFIED

Beresford, M; Glynne-Jones, R; Makris, A; Harrison, M; (2003) Lymph node staging following preoperative chemoradiation in rectal cancer. British Journal of Cancer , 88 S21 - S21.

Birtle, AJ; Masters, JRW; Freeman, A; Payne, HA; Harland, SJ; (2003) Clinical Features of Patients Who Present with Metastatic Prostate Carcinoma and Serum Prostate-Specific Antigen (PSA) Levels < 10 ng/mL: The "PSA Negative" Patients. Cancer , 98 (11) 2362 - 2367. 10.1002/cncr.11821.

Brada, M; Viviers, L; Abson, C; Hines, F; Britton, J; Ashley, S; ... Westbury, C; + view all (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol , 14 (12) 1715 - 1721.

Burcombe, RJ; Makris, A; Pittam, M; Finer, N; (2003) Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast , 12 (4) 290 - 293.

C

Calabrese, CR; Batey, MA; Thomas, HD; Durkacz, BW; Wang, LZ; Kyle, S; ... Curtin, NJ; + view all (2003) Identification of potent nontoxic poly(ADP-ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies. CLIN CANCER RES , 9 (7) 2711 - 2718.

Calvert, H; (2003) Developing drugs for cancer: Striking balance between clinical pragmatism and scientific allure. In: BRITISH JOURNAL OF CANCER. (pp. S7 - S7). NATURE PUBLISHING GROUP

Calvert, H; (2003) Pemetrexed (Alimta): A promising new agent for the treatment of breast cancer. SEMINARS IN ONCOLOGY , 30 (2) 2 - 5. 10.1053/sonc.2003.37267.

Carnell, D; Smith, R; Taylor, J; Stirling, J; Hoskin, P; Padhani, A; (2003) Evaluation of hypoxia within human prostate carcinoma using quantified bold MRI and pimonidazole immunohistochemical mapping. British Journal of Cancer , 88 S12 - S12.

Carnell, DM; Daley, FM; Smith, RE; Hoskin, P; Murray, GI; Everett, SA; (2003) CYP1B1 protein expression in prostate carcinoma. British Journal of Cancer , 88 S34 - S34.

Catherine, E; (2003) Thalidomide used in trials to cure cancer. Camden New Journal 25 - ?.

Clingen, PH; DeSilva, IU; Ghadessy, FJ; Thurston, DE; Hartley, JA; (2003) The role of nucleotide excision repair and homologous recombination in the sensitivity of mammalian cells to the minor groove crosslinking pyrrolo[2,1-c][1,4]benzodiazepine dimmer SJG-136(NSC694501). In: Proceeding of the American Association for Cancer Research. (pp. 2672 - ?).

Corrie, P; Spanswick, VJ; Sehmbi, R; Jonson, A; Shaw, J; Dowen, S; ... Hartley, JA; + view all (2003) Increased persistence of treosulfan-induced DNA interstrand crosslinks when combined with gemcitabine: Proof of principle within a phase I trial. In: Proceeding of the American Society of Clinical Oncology. (pp. 128 - ?).

D

Daly, ME; Makris, A; Reed, M; Lewis, CE; (2003) Hemostatic regulators of tumor angiogenesis: A source of antiangiogenic agents for cancer treatment? Journal of the National Cancer Institute , 95 (22) 1660 - 1673.

Dangoor, A; Ranson, M; Lee, SM; Beech, J; Sherlock, DJ; Wilkinson, PM; Valle, JW; (2003) Treatment of inoperable hepatocellular carcinoma (HCC) with pegylated liposomal doxorubicin (Caelyx). In: (Proceedings) 2003 ASCO Annual Meeting/39th Annual Meeting, Chicago, Illinois.. (pp. 361 - ?). Proceedings of the American Society of Clinical Oncology

David, F; (2003) Birth defects drug is poised for comeback. Financial Times

Davis, AM; Dische, S; Gerber, L; Saunders, M; Leung, SF; O'Sullivan, B; (2003) Measuring postirradiation subcutaneous soft-tissue fibrosis: State-of-the-art and future directions. Seminars in Radiation Oncology , 13 (3) 203 - 213.

de Bruin, EC; Meersma, D; de Wilde, J; den Otter, I; Schipper, EM; Medema, JP; Peltenburg, LT; (2003) A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death Differ , 10 (10) 1204 - 1212. 10.1038/sj.cdd.4401296.

Dearling, JL; Flynn, AA; Sutcliffe-Goulden, J; Boden, R; Boxer, GM; Begent, RHJ; Pedley, RB; (2003) Deoxyglucose microdistribution in major pathophysiological tumour compartments. In: Nuclear Medicine Communication. (pp. 24 - ?).

DeCanha, S; Hoskin, PJ; (2003) Current thinking of the role of radiotherapy in metastatic disease. In: Miles, A, (ed.) Key Advances in the effective Management of Breast Cancer. Royal College of Physicians: London.

Dische, S; Saunders, MI; (2003) Complexity and simplicity in the measurement and recording of the adverse effects of cancer treatment. Radiotherapy And Oncology , 66 (3) 249 - 251.

Dittrich, C; Dumez, H; Calvert, H; Hanauske, A; Faber, M; Wanders, J; ... Fumoleau, P; + view all (2003) Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors. CLIN CANCER RES , 9 (14) 5195 - 5204.

E

Eccersley, AJ; Wilson, EM; Makris, A; Novell, JR; (2003) Referral guidelines for colorectal cancer - do they work? Annals of the Royal College of Surgeons of England , 85 (2) 107 - 110.

F

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Dearling, J; Boden, RABRHJ; (2003) The heterogeneity of antibody distribution in kidney and its influence on dosimetry. Radiation Research , 159 182 - 189.

Flynn, AA; Pedley, RB; Green, AJ; Dearling, JL; El-Emir, E; Boxer, GM; ... Begent, RH; + view all (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. Radiat Res , 159 (2) 182 - 189.

Flynn, AA; Pedley, RB; Green, AJ; Dearling, JL; El-Emir, E; Boxer, GM; ... Begent, RHJ; + view all (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. RADIAT RES , 159 (2) 182 - 189.

Friedmann, BJ; Caplin, M; Hartley, JA; Hochhauser, D; (2003) UNSPECIFIED In: Proc. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Clinical Cancer Research

Friedmann, BJ; Caplin, M; Hartley, JA; Hochhauser, D; (2003) Modulation of the activity of chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib ('Iressa', ZD1839) in human cancer cell lines. In: CLINICAL CANCER RESEARCH. (pp. 6094S - 6094S). AMER ASSOC CANCER RESEARCH

G

Gaffan, J; Holden, L; Newlands, ES; Short, D; Fuller, S; Begent, RHJ; ... Seckl, MJ; + view all (2003) Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study. BRIT J CANCER , 89 (10) 1849 - 1854. 10.1038/sj.bjc.6601383.

Grigg, A; Solal-Celigny, P; Hoskin, P; Taylor, K; McMillan, A; Forstpointner, R; ... Hiddemann, W; + view all (2003) Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma. Leukemia and Lymphoma , 44 (9) 1503 - 1508.

Grimble, G; Taylor, RM; Cheeseman, P; Preedy, VR; Baker, AJ; (2003) Can energy expenditure be predicted in critically ill children? Pediatric Critical Care Medicine , 4 (2) 176 - 180.

H

Hammond, KL; Loynes, HE; Folarin, AA; Smith, J; Whitfield, TT; (2003) Hedgehog signalling is required for correct anteroposterior patterning of the zebrafish otic vesicle. DEVELOPMENT , 130 (7) 1403 - 1417. 10.1242/dev.00360.

Harney, J; Goodchild, K; Phillips, H; Glynne-Jones, R; Hoskin, PJ; Saunders, MI; (2003) A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. Clinical Oncology , 15 (3) 109 - 114.

Harney, J; Shah, N; Short, S; Saunders, M; Joiner, M; (2003) Low dose hyper-radiosensitivity-a clinical assessment. In: International journal of radiation oncology biology physics. (pp. Abs 173 - ?).

Hoskin, PJ; (2003) Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treatment Reviews , 29 (4) 321 - 327.

Hoskin, PJ; (2003) Case selection in the management of cerebral metastases. Clinical Oncology , 15 (7) 420 - 421.

Hoskin, PJ; (2003) What are the oncologist's need. European Journal of Nuclear Medicine and Molecular Imaging , 30 (S1) S37 - S41. 10.1007/s00259-003-1158-5.

Hoskin, PJ; (2003) Radiotherapy in symptom management. In: Doyle, D and Hanks, GW and Cherny, N and Calman, K, (eds.) Oxford Textbook of Palliative Care. Oxford University Press.: Oxford.

Hoskin, PJ; (2003) Evaluation and management of the patient with bone metastases at presentation. In: Jasmin, C and Caanna, R and Coia, L and Coleman, R and Diel, I, (eds.) Textbook of Bone Metastases. Wiley: Chichester.

Hoskin, PJ; Bownes, PJ; Ostler, P; Walker, K; Bryant, L; (2003) High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiotherapy And Oncology , 68 (3) 285 - 288.

Hoskin, PJ; Grover, A; Bhana, R; (2003) Metastatic spinal cord compression: radiotherapy outcome and dose fractionation. Radiotherapy And Oncology , 68 (2) 175 - 180.

Hoskin, PJ; O'Doherty, MJ; (2003) Lymphoma: Diagnosis and Management. European Journal Of Nuclear Medicine and Molecular Imaging , 30 (S1) BP87 - BP98. 10.1007/s00259-003-1342-7.

Hoskin, PJ; Sibtain, A; Daley, FM; Wilson, GD; (2003) GLUTI and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. British Journal of Cancer , 89 (7) 1290 - 1297. 10.1038/sj.bjc.6601260.

Howie, AJ; Turhan, N; Adu, D; (2003) Powerful morphometric indicator of prognosis in lupus nephritis. QJM , 96 (6) 411 - 420. 10.1097/01.TP.0000120177.44144.FF.

Huhalov, A; Spencer, DI; Chester, KA; (2003) Mapping Antibody:Antigen Interactions by Mass Spectrometry and Bioinformatics. In: Lo, BKC, (ed.) Antibody Engineering Methods and Protocols. (465 - 480). Humana Press

I

Irwin, HL; Corcoran, F; Boxer, GM; Pedley, RB; Dearling, J; Hartley, JM; ... Sharma, SK; + view all (2003) Isolation of tumour cells from peripheral blood for potential assessment of response to antibody directed enzyme prodrug therapy (ADEPT). British Journal of Cancer , 88 S37 - S37.

Irwin, HL; Corcoran, F; Boxer, GM; Pedley, RB; Dearling, J; Hartley, JM; ... Sharma, SK; + view all (2003) Isolation of tumour cells from peripheral blood for potential assessment of response to antibody directed enzyme prodrug therapy (ADEPT). In: BRITISH JOURNAL OF CANCER. (pp. S37 - S37). NATURE PUBLISHING GROUP

J

Jacqui, T; (2003) Thalidomide used to fight lung cancer. ‘Deformity’ drug in new trial. The Sun 16 - ?.

James, L; Lee, SM; (2003) A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC). In: (Proceedings) 10th World Conference on Lung Cancer, Vancouver.. (pp. S183 - ?). Lung Cancer

James, M; (2003) Lung cancer curbed in thalidomide trial. The Guardian

Janinis, J; Patriki, M; Vini, L; Aravantinos, G; Whelan, JS; (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Annals of Oncology , 14 181 - 190.

John, G; (2003) Thalidomide. An unlikely cure? Guardian 60 - ?.

John, T; Ottley, C; Pearson, G; Nowell, G; Calvert, H; Tilby, M; (2003) Sensitive determination of BBR 3464 and cisplatin DNA adduct levels in clinical samples using ICP-MS and PIMMS. In: BRITISH JOURNAL OF CANCER. (pp. S42 - S42). NATURE PUBLISHING GROUP

John, T; Ottley, CJ; Pearson, DG; Nowell, GM; Calvert, H; Tilby, MJ; (2003) Determination, by ICP-MS, of background and BBR 3464 induced levels of platinum bound to DNA isolated from blood cells: A comparison of the sensitivity of the Perkin Elmer Sciex Elan 6000 and the thermofinnigan Neptune instruments. In: Holland, JG and Tanner, SD, (eds.) PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES. (pp. 82 - 90). ROYAL SOC CHEMISTRY

K

Kate, N; (2003) Bag Drug Makes Good. TIME Magazine 59 - ?.

Kauppila, S; Maaty, WS; Chen, P; Tomar, RS; Eby, MT; Chapo, J; ... Chaudhary, PM; + view all (2003) Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene , 22 (31) 4860 - 4867. 10.1038/sj.onc.1206715.

Khalil, AA; Bentzen, SM; Bernier, J; Saunders, MI; Horiot, JC; Van Den Bogaert, W; ... Dische, S; + view all (2003) Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. International Journal of Radiation Oncology Biology Physics , 55 (3) 568 - 575.

Kostoula, V; Khan, K; Savage, K; Hochhauser, D; Stubbs, M; McStay, M; ... Caplin, ME; + view all (2003) Expression of c-kit (cd117) in neuroendocrine tumours - a target for therapy? ENDOCR-RELAT CANCER , 10 (4) 508 - 508.

Kotecha, MT; Hercus, L; Lees, SM; Hartley, JA; Hochhauser, D; (2003) Modulation of topoisomerase Iia expression by sequence specific polyamides. In: Proceeding of the American Association for Cancer Research. (pp. 6539 - ?).

Krause, M; Hessel, F; Wohlfarth, J; Zips, D; Hoinkis, C; Foest, H; ... Baumann, M; + view all (2003) Ultrafractionation in A7 malignant glioma in nude mice. 377 - 383.

Kristeleit, RS; Stimson, L; Workman, P; Aherne, GW; (2003) Effects of the hydroxamic acid histone deacetylase inhibitors trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA) and LAQ824 on histone and protein acetylation. In: CLINICAL CANCER RESEARCH. (pp. 6107S - 6107S). AMER ASSOC CANCER RESEARCH

L

Lacombe, D; Butler-Smith, A; Therasse, P; Fumoleau, P; Burtles, S; Calvert, H; ... Verweij, J; + view all (2003) Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network. CANCER INVEST , 21 (1) 137 - 147. 10.1081/CNV-120016408.

Lambert, S; Mason, SJ; Barber, LJ; Hartley, JA; Pearce, JA; Carr, AM; McHugh, PJ; (2003) Schizosaccharomyces pombe checkpoint response to DNA interstrand cross-links. MOL CELL BIOL , 23 (13) 4728 - 4737.

Lee, M; Wilson, D; Lacy, E; Grandillo, J; Le, M; Kiakos, K; Hartley, J; (2003) Microcalorimetry and DNase I footprinting studies on the molecular recognition of T/G mismatched base pairs by stacked polyamides. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U199 - U200). AMER CHEMICAL SOC

Lee, YC; Flora, R; McCafferty, JA; Gor, J; Tsaneva, IR; Perkins, SJ; (2003) A tetramer-octamer equilibrium in Mycobacterium leprae and Escherichia coli RuvA by analytical ultracentrifugation. J MOL BIOL , 333 (4) 677 - 682. 10.1016/j.jmb.2003.08.047.

Leonard, P; Sharp, T; Henderson, S; Hewitt, D; Pringle, J; Sandison, A; ... Boshoff, C; + view all (2003) Gene expression array profile of human osteosarcoma. BRIT J CANCER , 89 (12) 2284 - 2288. 10.1038/sj.bjc.6601389.

Leverrier, Y; Okkenhaug, K; Sawyer, C; Bilancio, A; Vanhaesebroeck, B; Ridley, AJ; (2003) Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages. J Biol Chem , 278 (40) 38437 - 38442. 10.1074/jbc.M306649200. Gold open access

Leverrier, Y; Okkenhaug, K; Sawyer, C; Bilancio, A; Vanhaesebroeck, B; Ridley, AJ; (2003) Class I PI3K p110b is required for apoptotic cell and FcgR-mediated phagocytosis by macrophages. Journal of Biological Chemistry , 278 38437 - 38442. Gold open access

Lewis, I; Nooij, M; Whelan, J; Casak, S; Memon, M; Taminiau, A; ... Intergroup, AKOBOTEO; + view all (2003) Chemotherapy at standard or increased dose intensity in patients with operable osteosarcoma of the extremity: A randomised controlled trial of the European Osteosarcoma Intergroup (ISRCTN 86294690). In: SIOP, Cairo, Oct 2003.

LoRusso, PM; Herbst, RS; Rischin, D; Ranson, M; Calvert, H; Raymond, E; ... Baselga, J; + view all (2003) Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. CLIN CANCER RES , 9 (6) 2040 - 2048.

Lyn, BE; Wilson, EM; Williams, FJ; Saunders, MI; Phillips, H; (2003) Chart to Chartwel to Chemotherapy and Chartwel in Non-Small Cell Lung Cancer. British Journal of Cancer , 88 S23 - S23.

M

Mackay, HJ; O'Brien, M; Hill, S; Lee, SM; Thatcher, N; Smith, IE; Dunlop, DJ; (2003) A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer. Clinical Oncology , 15 (4) 181 - 185.

Makris, A; (2003) Critical commentary of: Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin and flourouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer:an EORTC-NCIC-SAKK multicenter study. Women's Oncology Review , 3 237 - 238.

Martin, F; Chowdhury, S; Neil, SJ; Chester, KA; Cosset, FL; Collins, MK; (2003) Targeted retroviral infection of tumor cells by receptor cooperation. J VIROL , 77 (4) 2753 - 2756. 10.1128/JVI.77.4.2753-2756.2003.

Martin, M; Spielmann, M; Namer, M; duBois, A; Unger, C; Dodwell, D; ... Zielinski, C; + view all (2003) Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines. ANN ONCOL , 14 (8) 1246 - 1252. 10.1093/annonc/mdg339.

Mayer, A; Tsiompanou, E; Flynn, AA; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2003) Higher dose and dose-rate in smaller tumors result in improved tumor control. CANCER INVEST , 21 (3) 382 - 388. 10.1081/CNV-120018229.

Meyer, T; McTiernan, A; Whelan, J; (2003) A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours. Sarcoma , 7 (1) 13 - 17. 10.1080/1357714031000114192. Gold open access

Murphy, DM; Dolbear, C; Moller, H; Whelan, JS; Pinkerton, CR; (2003) The incidence of cancer in adolescents and young adults in south east England: an analysis of Thames Cancer Registry data 1998-2000. In: British Cancer Research Meeting, Bournemouth June 2003. Br J Cancer 2003; 88 Suppl 1:S17.

N

Nathan, PD; Hochhauser, D; (2003) Pathogenesis of Cancer. In: Kirk, RM and Ribbans, WJ, (eds.) Clinical Surgery in General. Charchill Livingstone: London.

Nooij, M; Lewis, I; Whelan, JS; Casak, S; Memon, M; Hogendoorn, P; ... Kirkpatrick, A; + view all (2003) Does increasing dose intensity in patients with operable osteosarcoma of the extremity improve outcome? A randomised controlled trial of the European Osteosarcoma Intergroup (EOI). In: ECCO, Copenhagen Oct 2003.

O

Okkenhaug, K; Vanhaesebroeck, B; (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol , 3 (4) 317 - 330. 10.1038/nri1056.

Okkenhaug, K; Vanhaesebroeck, B; (2003) PI3K-signalling in B- and T-cells: insights from gene-targeted mice. Biochem Soc Trans , 31 (Pt 1) 270 - 274.

P

Plummer, R; Rees, C; Hughes, A; Beale, P; Highley, M; Trigo, J; ... Douglass, E; + view all (2003) A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor. CLIN CANCER RES , 9 (4) 1313 - 1322.

R

Redpath, JL; Short, SC; Woodcock, M; Johnston, P; (2003) Low dose reduction in transformation frequency compared to unirradiated controls: the role of hyper-radiosensitivity. Radiation Research , 159 433 - 436.

Reigner, B; Watanabe, T; Schüller, J; Lucraft, H; Sasaki, Y; Bridgewater, J; ... Grange, S; + view all (2003) Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer. Cancer Chemother Pharmacol , 52 (3) 193 - 201. 10.1007/s00280-003-0642-8.

Rob, B; (2003) Controversial drug in lung cancer trials. Highbury & Islington Express

Roos, DE; Davis, SR; Turner, SL; O'Brien, PC; Spry, NA; Burmeister, BH; ... Ball, DL; + view all (2003) Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05). Radiotherapy And Oncology , 67 (2) 207 - 212.

S

Sarker, D; Williams, MT; Buscombe, J; Caplin, M; Hochhauser, D; Begent, R; Meyer, T; (2003) Streptozocin, 5-fluorouracil/folinic acid and cisplatin (FCiSt) for advanced neuroendocrine tumours. British Journal of Cancer , 88 S65 - S65.

Saunders, M; Palmer, AM; Millard, RK; Preece, AW; (2003) Doses to fetal and maternal organs from intravenous (FeCl3)-Fe- 59 or (CoCl2)-Co-57. Radiation Protection Dosimetry , 106 (1) 63 - 69.

Sawyer, C; Sturge, J; Bennett, DC; O'Hare, MJ; Allen, WE; Bain, J; ... Vanhaesebroeck, B; + view all (2003) Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. Cancer Res , 63 (7) 1667 - 1675.

Sayle, KL; Bentley, J; Boyle, FT; Calvert, AH; Cheng, YZ; Curtin, NJ; ... Griffin, RJ; + view all (2003) Structure-based design of 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinases 1 and 2. BIOORG MED CHEM LETT , 13 (18) 3079 - 3082. 10.1016/S0960-894X(03)00651-6.

Sharma, SK; Pedley, RB; Irwin, HL; El Emir, E; Boxer, GM; Boden, RW; ... Begent, RHJ; + view all (2003) The effect of ADEPT, as a single or combined therapy, in two colorectal xenografts. In: British Journal of Cancer. (pp. S37 - S37).

Sharma, SK; Pedley, RB; Irwin, HL; El-Emir, E; Boxer, GM; Boden, RW; ... Begent, RHJ; + view all (2003) The effect of adept, as a single or combined therapy, in two colorectal xenografts. In: BRITISH JOURNAL OF CANCER. (pp. S37 - S37). NATURE PUBLISHING GROUP

Short, S; (2003) UNSPECIFIED In: (Proceedings) 2nd International Conference on Translational Research in Radiation Oncology.

Short, S; (2003) External beam and conformal radiotherapy in the management of gliomas. In: Westphal,, (ed.) Local therapies for glioma. Springer

Short, S; Buffa, F; Bourne, S; Johnston, P; Bentzen, S; (2003) Determining dose response relationships of gene expression in human tumour cells after low radiation doses using micro-array analysis. In: Proc EU-US Molecular Signatures of DNA Damage Workshop.

Short, S; C, B; F, B; S, J; P, B; S, M; (2003) UNSPECIFIED In: (Proceedings) EU-US Molecular Signatures of DNA Damage Workshop.

Short, S; C, H; J,; (2003) Radiobiology and vascular targeting in glioma. Current opinion in neurology , 16 651 - 655.

Sibtain, A; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2003) Pre-treatment Haemoglobin Concentration in Accelerated and Conventional Radiotherapy for Non-small Cell Lung Carcinoma. Clinical Oncology , 16 58 - 62.

Skalitzky, DJ; Marakovits, JT; Maegley, KA; Ekker, A; Yu, XH; Hostomsky, Z; ... Golding, BT; + view all (2003) Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J MED CHEM , 46 (2) 210 - 213. 10.1021/jm0255769.

Smellie, M; Bose, DS; Thompson, AS; Jenkins, TC; Hartley, JA; Thurston, DE; (2003) Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: Kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers. BIOCHEMISTRY-US , 42 (27) 8232 - 8239. 10.1021/bi034313t.

Stein, ME; Lewis, DC; Gershuny, AR; Quigley, MM; Zaidan, J; Siegelmann-Danieli, N; ... Subramanian, R; + view all (2003) Trauma as an etiologic factor of primary bone lymphoma: a report of 4 cases. Journal of BUON , 8 163 - 166.

Strauss, SJ; Marples, M; Napier, MP; Meyer, T; Boxall, J; Rustin, GJS; (2003) A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma. British Journal of Cancer , 89 (10) 1901 - 1905.

Strauss, SJ; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, AM; ... Whelan, JS; + view all (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. Journal of Clinical Oncology , 21 (15) 2974 - 2981. 10.1200/JCO.2003.04.106.

Strauss, SJ; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, AM; ... Whelan, JS; + view all (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. J CLIN ONCOL , 21 (15) 2974 - 2981. 10.1200/JCO.2003.04.106.

T

The, T; (2003) Conditions: Lung Cancer.

Toth, J; Henry, J; Taherbhai, Z; Staples, T; Summerville, K; Handl, H; ... Lee, M; + view all (2003) Cytotoxicity and sequence specificity of C- and N-terminus conjugates of N-methylpyrrole polyamides with seco-cyclopropaneindoline. MED CHEM RES , 12 (2) 87 - 93.

Tsotinis, A; Vlachou, M; Kiakos, K; Hartley, JA; Thurston, DE; (2003) Design and synthesis of two cytotoxic analogs of the novel pyrrolo[1 ',2 ': 1,2][1,4]diazepin [7,6-b]indol-5(6H)-one nucleus. CHEM LETT , 32 (6) 512 - 513. 10.1246/cl.2003.512.

Turner, NC; Hochhauser, D; (2003) New Targets in oesophagogastric cancer. In: Key Advances in Clinical Practice: The Effective Management of Oesophagogastric Cancer. Aesculapius Press

U

UCL, PA; (2003) Scans help spot lung cancer early. 29 - ?.

Urbaniak, MD; Frost, LM; Bingham, JP; Kelland, LR; Hartley, JA; Woolfson, DN; Caddick, S; (2003) Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore. BIOORG MED CHEM LETT , 13 (12) 2025 - 2027. 10.1016/S0960-894X(03)00328-7.

V

Vassileva, VT; (2003) Analysis of Genetic Targets Contributing to Mutator Phenotype of Endometrial Cancer. Masters thesis, University of Toronto.

Venables, K; Winfield, EA; Aird, EGA; Hoskin, PJ; (2003) Three-dimensional distribution of radiation within the breast: An intercomparison of departments participating in the start trial of breast radiotherapy fractionation. International Journal of Radiation Oncology Biology Physics , 55 (1) 271 - 279.

W

Wells, G; Gale, T; Hardy, A; Hamaguchi, A; Hartley, JA; Wilkinson, GP; ... Thurston, DE; + view all (2003) Pyrrolobenzodiazepine-polyamide libraries:synthesis and DNA binding selectivity. Proceeding of the American Association for Cancer Research. In: Proceeding of the American Association for Cancer Research. (pp. 452 - ?).

Wells, P; Aboagye, E; Gunn, RN; Osman, S; Boddy, AV; Taylor, GA; ... Newell, DR; + view all (2003) 2-[C-11]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337. J NATL CANCER I , 95 (9) 675 - 682.

Westbury, CB; Harrington, KJ; Rhys-Evans, P; Archer, DJ; Searle, AE; Henk, JM; ... Nutting, CM; + view all (2003) Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. POSTGRAD MED J , 79 (929) 176 - 177.

Whelan, J; (2003) Studies on cellular sensitivity and resistance to cytosine arabinoside. UNSPECIFIED thesis, UNSPECIFIED.

Whelan, J; (2003) Where should teenagers with cancer be treated? European Journal of Cancer , 39 (18) 2573 - 2578. 10.1016/j.ejca.2003.09.014.

Whelan, JS; (2003) Working with Adolescents. ESMO Summer Educational Conference, Edinburgh June 2003. In: Annals Oncol. (pp. 42 - ?).

Whelan, JS; McTiernan, A; (2003) Survival after recurrence of Ewing’s tumour is improved by high dose chemotherapy and surgery. Results of a retrospective analysis of 116 patients. In: Connective Tissue Oncology Society, Barcelona Nov 2003.

Whelan, JS; O, SC; Stanway, S; Ng, S; (2003) How should glomerular filtration rates be measured in teenagers having chemotherapy? In: British Cancer Research Meeting, Bournemouth June 2003. Br J Cancer 2003; 88 Suppl 1:S53.

Wilkinson, GP; Loadman, P; Taylor, J; Jenkins, TC; Swaine, D; Double, JA; ... Thurston, DE; + view all (2003) Pharmacokinetic and intracellular pharmacological characteristics of the novel pyrrolobenzodiazepine (PBD) dimmer SJG-136. In: Proceeding of the American Association for Cancer Research. (pp. 1634 - ?).

Winfield, EA; Deighton, A; Venables, K; Hoskin, PJ; Aird, EGA; (2003) Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer. British Journal of Radiology , 76 (904) 254 - 259.

Wong, WL; Saunders, M; (2003) The impact of FDG PET on the management of occult primary head and neck tumours. Clinical Oncology , 15 (8) 461 - 466.

This list was generated on Sun Apr 20 03:32:24 2014 BST.